Not finding it? Sign in to also search OpenAlex live.
-
Analytical and Clinical Validation of the Oncomine Dx Target Test to Assess HER2 Mutation Status in Tumor Tissue Samples From Patients With Non–Small Cell Lung Cancer Treated With Trastuzumab Deruxtecan in the DESTINY-Lung01 and DESTINY-Lung02 Studies2024 Archives of Pathology & Laboratory Medicine article Medicine Lung Cancer Treatments and Mutations Open access
Zhenhao Qi, Wenqin Feng, Maha Karnoub, Kaline Pereira, Ryota Shiga, Egbert Frederik Smit, +5 more
5citations -
Trastuzumab-Emtansine and Osimertinib Combination Therapy to Target HER2 Bypass Track Resistance in EGFR Mutation-Positive NSCLC2023 JTO Clinical and Research Reports article Medicine Lung Cancer Treatments and Mutations Open access
M. Jebbink, Adrianus Johannes De Langen, Kim Monkhorst, Mirjam C. Boelens, Daan van den Broek, Vincent van der Noort, +8 more
24citations -
Nationwide evaluation of mutation-tailored anti-EGFR therapy selection in patients with colorectal cancer in daily clinical practice2021 Journal of Clinical Pathology article Medicine Colorectal Cancer Treatments and Studies Open access
Elisabeth M. P. Steeghs, Geraldine R. Vink, Marloes A.G. Elferink, Quirinus J.M. Voorham, Hans A. J. Gelderblom, Irıs D. Nagtegaal, +2 more
0citations -
Clonal haematopoiesis of indeterminate potential and impaired kidney function—A Danish general population study with 11 years follow‐up2022 European Journal Of Haematology article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Morten Kranker Larsen, Vibe Skov, Lasse Kjær, Natascha A. Møller‐Palacino, Rasmus Kristoffer Pedersen, Morten Andersen, +14 more
18citations -
Quantitative modeling of tumor dynamics and development of drug resistance in non‐small cell lung cancer patients treated with erlotinib2024 CPT Pharmacometrics & Systems Pharmacology article Medicine Lung Cancer Treatments and Mutations Open access
Anyue Yin, G. Veerman, J. G. Coen van Hasselt, Christi M. J. Steendam, Hendrikus Jan Dubbink, Henk‐Jan Guchelaar, +4 more
6citations -
Ripretinib Versus Sunitinib in Patients With Advanced Gastrointestinal Stromal Tumor After Treatment With Imatinib (INTRIGUE): A Randomized, Open-Label, Phase III Trial2022 Journal of Clinical Oncology article Medicine Gastrointestinal Tumor Research and Treatment Open access
Sebastian Bauer, Robin L. Jones, Jean‐Yves Blay, Hans A. J. Gelderblom, Suzanne George, Patrick Schöffski, +13 more
121citations -
Mathematical modelling of stem and progenitor cell dynamics during ruxolitinib treatment of patients with myeloproliferative neoplasms2024 Frontiers in Immunology article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Tobias Idor Boklund, Johanne Gudmand‐Hoeyer, Morten Kranker Larsen, Trine Alma Knudsen, Christina Schjellerup Eickhardt‐Dalbøge, Vibe Skov, +5 more
8citations -
Clinicohematologic and molecular response of essential thrombocythemia patients treated with pegylated interferon-α: a multi-center study of the German Study Group-Myeloproliferative Neoplasms (GSG-MPN)
Frank Stegelmann, Lino Lars Teichmann, Florian Heinrich Heidel, Carl C. Crodel, Thomas Ernst, Sebastian Kreil, +11 more
8citations